Abivax SA is positioning to change the treatment landscape in ulcerative colitis after delivering positive results and a favorable safety profile in two phase III trials of its orally available ...

The Figma IPO has plenty of buzz building around it, with the design software company expected to start trading next week.

Elastic is well-positioned to benefit from AI trends, with its leadership in vector search and growing cloud revenue likely ...

Kohl’s stock has gone bonkers, and meme stocks look to be back in fashion. There’s a laundry list of candidates to join the party.

The U.S. money supply is increasing, with the latest data showing the fastest rise in three years. It’s likely giving a helpful hand to the stock market. Money supply, as measured by M2, sums up the ...

Unity Software (NYSE: U) gave investors a reason to take notice in mid-July 2025. The company’s stock jumped over 14% to a ...

Shares of Sarepta Therapeutics declined 17% in early trading on Friday after another patient who had received an experimental ...

Unity's (NYSE:U) stock popped twelve percent after Morgan Stanley spotlighted a clear turnaround in its ad business.

Unity (U) has been on an impressive run, with its stock surging 97% over the past three months. Much of the momentum comes ...

Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell cultureBorrelia and Bartonella, together with Babesia, represent the "3Bs," ...

The S&P 500 climbed 0.61% on Wednesday (July 9), driven by gains in tech stocks as Nvidia hit a historic milestone and ...

Unity Software is undergoing a strategic transformation, shedding underperforming segments to become more focused, profitable, and efficient. See why U stock is a Buy.